Loading...
Waters Corporation
WAT•NYSE
Healthcare
Medical - Diagnostics & Research
$352.57
$2.56(0.73%)
Waters Corporation (WAT) Financial Performance & Statements
Review Waters Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.07%
↑ 0.07%
Operating Income Growth
1.06%
↑ 1.06%
Net Income Growth
-0.69%
↓ 0.69%
Operating Cash Flow Growth
26.43%
↑ 26.43%
Operating Margin
28.37%
↑ 28.37%
Gross Margin
62.08%
↑ 62.08%
Net Profit Margin
22.02%
↑ 22.02%
ROE
38.61%
↑ 38.61%
ROIC
23.31%
↑ 23.31%
Waters Corporation (WAT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Waters Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $872.71M | $740.30M | $708.53M | $636.84M |
| Cost of Revenue | $348.52M | $313.25M | $300.90M | $273.83M |
| Gross Profit | $524.20M | $427.06M | $407.63M | $363.01M |
| Gross Profit Ratio | $0.60 | $0.58 | $0.58 | $0.57 |
| R&D Expenses | $46.91M | $45.34M | $46.18M | $44.59M |
| SG&A Expenses | $173.27M | $172.10M | $170.25M | $174.54M |
| Operating Expenses | $231.94M | $217.43M | $216.43M | $219.13M |
| Total Costs & Expenses | $568.70M | $529.17M | $517.33M | $492.96M |
| Interest Income | $4.56M | $4.26M | $4.33M | $4.27M |
| Interest Expense | $19.00M | $21.43M | $23.73M | $25.52M |
| Depreciation & Amortization | $48.58M | $47.51M | $47.23M | $48.51M |
| EBITDA | $344.55M | $262.56M | $236.40M | $192.60M |
| EBITDA Ratio | $0.39 | $0.35 | $0.33 | $0.30 |
| Operating Income | $292.26M | $211.13M | $191.20M | $143.88M |
| Operating Income Ratio | $0.33 | $0.29 | $0.27 | $0.23 |
| Other Income/Expenses (Net) | -$15.28M | -$17.52M | -$19.70M | -$18.99M |
| Income Before Tax | $276.98M | $193.62M | $169.41M | $114.86M |
| Income Before Tax Ratio | $0.32 | $0.26 | $0.24 | $0.18 |
| Income Tax Expense | $45.59M | $32.11M | $26.68M | $12.66M |
| Net Income | $231.40M | $161.50M | $142.74M | $102.20M |
| Net Income Ratio | $0.27 | $0.22 | $0.20 | $0.16 |
| EPS | $3.90 | $2.72 | $2.41 | $1.73 |
| Diluted EPS | $3.88 | $2.71 | $2.40 | $1.72 |
| Weighted Avg Shares Outstanding | $59.39M | $59.31M | $59.34M | $59.23M |
| Weighted Avg Shares Outstanding (Diluted) | $59.65M | $59.50M | $59.45M | $59.43M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan